Industry Symposium by Bayer

IND 31 - Future Directions in Liver Disease – preparing for increased prevalence and optimizing collaboration for better patient care

(1) Where is Liver Disease heading in Europe?: An Outlook and Perspective from the European Association of the Study of the Liver (EASL).
(2) Best practices in screening/surveillance, diagnosis and follow-up. Current challenges in HCC treatment stratification and response prediction.
(3) Precision Imaging in Radiology: Current Options and Future Potential.

20 min
Where is Liver Disease heading in Europe?: An Outlook and Perspective from the European Association of the Study of the Liver (EASL)
Thomas Berg, LEIPZIG / Germany
20 min
Best practices in screening/surveillance, diagnosis and follow-up. Current challenges in HCC treatment stratification and response prediction
Muşturay Karçaaltincaba, Ankara / Turkey
20 min
Precision Imaging in Radiology: Current Options and Future Potential
Timo Alexander Auer, Berlin / Germany

Lectures

1
Where is Liver Disease heading in Europe?: An Outlook and Perspective from the European Association of the Study of the Liver (EASL)

Where is Liver Disease heading in Europe?: An Outlook and Perspective from the European Association of the Study of the Liver (EASL)

20:00Thomas Berg, LEIPZIG / DE

2
Best practices in screening/surveillance, diagnosis and follow-up. Current challenges in HCC treatment stratification and response prediction

Best practices in screening/surveillance, diagnosis and follow-up. Current challenges in HCC treatment stratification and response prediction

20:00Muşturay Karçaaltincaba, Ankara / TR

3
Precision Imaging in Radiology: Current Options and Future Potential

Precision Imaging in Radiology: Current Options and Future Potential

20:00Timo Alexander Auer, Berlin / DE